Rydex Europe Advantage Fund Class A (RYAEX)
| Fund Assets | 2.02M |
| Expense Ratio | 1.66% |
| Min. Investment | $2,500 |
| Turnover | 4,585.00% |
| Dividend (ttm) | 7.25 |
| Dividend Yield | 5.42% |
| Dividend Growth | -39.41% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 16, 2025 |
| Previous Close | 127.22 |
| YTD Return | -1.78% |
| 1-Year Return | 26.93% |
| 5-Year Return | 52.82% |
| 52-Week Low | 96.39 |
| 52-Week High | 133.90 |
| Beta (5Y) | n/a |
| Holdings | 59 |
| Inception Date | Mar 31, 2004 |
About RYAEX
The Rydex Series Funds - Rydex Europe 1.25x Strategy Fund is a mutual fund designed to deliver investment results that correspond, before fees and expenses, to 125% of the daily performance of the STOXX Europe 50® Index. This means the fund seeks leveraged exposure, amplifying the returns (both positive and negative) of its European large-cap equity benchmark by 1.25 times each day. The fund accomplishes this by investing primarily in common stocks of companies included in the underlying index, as well as using leveraged financial instruments such as equity swaps. Notably, the fund targets established companies across multiple European sectors, providing investors with a means to access and magnify movements in major European equity markets. Managed by a team and overseen by Security Investors, LLC, the fund has been available since 2004 and distributes income annually, if applicable. With a gross expense ratio of 1.74%, it is structured for investors seeking active, leveraged participation in European equities within a regulated mutual fund vehicle.
Performance
RYAEX had a total return of 26.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.76%.
Top 10 Holdings
54.88% of assets| Name | Symbol | Weight |
|---|---|---|
| J.P. Morgan Securities Llc | n/a | 17.37% |
| Bofa Securities, Inc. | n/a | 12.50% |
| United States Treasury Bills 3.93% | B.0 10.14.25 | 6.83% |
| Guggenheim Ultra Short Duration Fund Institutional | GIYIX | 3.48% |
| Guggenheim Strategy II | n/a | 3.38% |
| ASML Holding N.V. | ASML | 3.10% |
| SAP SE | SAP | 2.24% |
| Novartis AG ADR | NVSN.MX | 2.03% |
| HSBC Holdings PLC ADR | HBC2.DE | 2.01% |
| AstraZeneca PLC | AZN | 1.95% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $7.25231 | Dec 16, 2025 |
| Dec 12, 2024 | $11.96903 | Dec 12, 2024 |
| Dec 12, 2023 | $0.74513 | Dec 12, 2023 |
| Dec 9, 2020 | $4.55411 | Dec 9, 2020 |
| Dec 10, 2019 | $0.44033 | Dec 10, 2019 |
| Dec 11, 2018 | $6.30238 | Dec 11, 2018 |